Custom Index Systems’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.46M Sell
7,437
-268
-3% -$52.1K 0.63% 37
2025
Q4
$1.34M Sell
7,705
-3,954
-34% -$720K 0.59% 40
2025
Q3
$2.22M Buy
11,659
+4,453
+62% +$790K 0.66% 31
2025
Q2
$1.29M Sell
7,206
-127
-2% -$22.1K 0.62% 34
2025
Q1
$1.24M Buy
7,333
+479
+7% +$78.7K 0.63% 31
2024
Q4
$1.03M Buy
6,854
+655
+11% +$102K 0.56% 48
2024
Q3
$962K Buy
6,199
+2,741
+79% +$409K 0.52% 56
2024
Q2
$473K Buy
3,458
+356
+11% +$48.8K 0.27% 92
2024
Q1
$413K Buy
+3,102
New +$402K 0.23% 134

Other funds holding DGX

Custom Index Systems's DGX Position: Q1 2026 in Review

Custom Index Systems reduced its Quest Diagnostics (DGX) stake by 3.5% in Q1 2026, selling an estimated $52.1K and leaving 7,437 shares worth $1.46M. The position accounts for 0.63% of the portfolio, ranked #37.

Custom Index Systems first reported a position in DGX in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.22M in Q3 2025. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Custom Index Systems held 7,437 shares of Quest Diagnostics worth $1.46M as of Q1 2026.
  • Custom Index Systems sold 268 Quest Diagnostics shares in Q1 2026, an estimated $52.1K.
  • Quest Diagnostics made up 0.63% of Custom Index Systems's portfolio in Q1 2026, its #37 holding.
  • Custom Index Systems first reported a position in Quest Diagnostics in Q1 2024 and has held it in 9 quarters since.
  • Custom Index Systems's Quest Diagnostics position peaked at $2.22M in Q3 2025.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Custom Index Systems's 13F filing for Q1 2026, filed 29 Apr 2026.